BWAY Stock Analysis

BWAY -  USA Stock  

USD 10.53  0.28  2.59%

The current rise in Brainsway short term price appreciation could raise concerns from investors as the firm it trading at a share price of 10.53 on 42,600 in volume. The company management teams have successfully maneuvered the firm at convenient times to take advantage of all market conditions in May. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.8. The current volatility is consistent with the ongoing market swings in May 2021 as well as with Brainsway unsystematic, company-specific events.
Continue to Trending Equities.

Search Stock Analysis 

 
Refresh
The Brainsway stock analysis report makes it easy to digest most publicly released information about Brainsway and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. BWAY stock analysis module also helps to analyze the Brainsway price relationship with some important fundamental indicators such as market cap and management efficiency.

BWAY Stock Analysis Notes

About 13.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.48. Brainsway ADR had not issued any dividends in recent years. Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 100 people. For more info on Brainsway Ltd ADR please contact the company at 972 2 582 4030 or go to http://www.brainsway.com.

Brainsway ADR Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Brainsway's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Brainsway Ltd ADR or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Brainsway ADR has high likelihood to experience some financial distress in the next 2 years
Brainsway Ltd ADR was previously known as Brainsway Ltd Ord and was traded on OTC Exchange under the symbol BRSYF.
The company reported the previous year's revenue of 22.06 M. Net Loss for the year was (5.38 M) with profit before overhead, payroll, taxes, and interest of 18.06 M.
Brainsway Ltd ADR currently holds about 17.18 M in cash with (1.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.04.
Brainsway ADR has a frail financial position based on the latest SEC disclosures
Latest headline from www.equities.com: Brainsway Ltd - ADR falls -2.8730 percent for June 16 - Equities.com

Brainsway ADR Upcoming and Recent Events

Earnings reports are used by Brainsway to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Brainsway previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report11th of August 2021
Next Earnings Report17th of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End23rd of March 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

BWAY Largest EPS Surprises

Earnings surprises can significantly impact Brainsway's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-11-18
2020-09-30-0.0533-0.040.013324 
2020-03-23
2019-12-31-0.115-0.10.01513 
2021-03-24
2020-12-31-0.0433-0.020.023353 
View All Earnings Estimates

Brainsway SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Brainsway prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Brainsway investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Brainsway ADR specific information freely available to individual and institutional investors to make a timely investment decision.
3rd of June 2021
Other Events. Unclassified Corporate Event
View
2nd of June 2021
Other Events
View
1st of June 2021
Other Events
View
24th of May 2021
Other Events
View
20th of May 2021
Other Events
View
5th of May 2021
Other Events
View
4th of May 2021
Unclassified Corporate Event
View
26th of April 2021
Other Events
View

BWAY Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Brainsway is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Brainsway Ltd ADR backward and forwards among themselves. Brainsway's institutional investor refers to the entity that pools money to purchase Brainsway's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Rtw Investments LpCommon Shares1.6 M14.5 M
Wasatch Advisors IncCommon SharesM9.2 M
Cowen And Company LlcCommon Shares978.8 K8.8 M
Cannell Capital LlcCommon Shares844 K7.6 M
Aigh Capital Management LlcCommon Shares760 K6.9 M
Phoenix Holdings LtdCommon Shares756.9 K6.8 M
Masters Capital Management LlcCommon Shares300 K2.7 M
Note, although Brainsway's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

BWAY Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 175.96 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Brainsway's market, we take the total number of its shares issued and multiply it by Brainsway's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

BWAY Profitablity

Brainsway's profitability indicators refer to fundamental financial ratios that showcase Brainsway's ability to generate income relative to its revenue or operating costs. If, let's say, Brainsway is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Brainsway's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Brainsway's profitability requires more research than a typical breakdown of Brainsway's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (24.41) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (17.08) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.17.
Last ReportedProjected for 2021
Return on Average Assets(0.15) (0.16) 
Return on Average Equity(0.25) (0.27) 
Return on Invested Capital(0.47) (0.50) 
Return on Sales(0.22) (0.24) 

Management Efficiency

The entity has return on total asset (ROA) of (6.47) % which means that it has lost $6.47 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (24.56) %, meaning that it created substantial loss on money invested by shareholders. Brainsway management efficiency ratios could be used to measure how well brainsway adr manages its routine affairs as well as how well it operates its assets and liabilities. Return on Average Assets is likely to drop to -0.16 in 2021. Return on Average Equity is likely to drop to -0.27 in 2021. Brainsway Total Assets are fairly stable at the moment as compared to the past year. Brainsway reported Total Assets of 34.01 Million in 2020. Current Assets is likely to rise to about 25 M in 2021, whereas Asset Turnover is likely to drop 0.60 in 2021.
Last ReportedProjected for 2021
Book Value per Share 1.77  1.83 
Enterprise Value over EBIT(13.00) (14.03) 
Enterprise Value over EBITDA(28.91) (31.19) 
Price to Book Value 4.27  4.06 
Tangible Assets Book Value per Share 3.06  3.31 
Enterprise Value62.2 M66.7 M
Tangible Asset Value34 M35.8 M

Technical Drivers

As of the 19th of June, Brainsway shows the risk adjusted performance of 0.0944, and Mean Deviation of 1.86. Brainsway ADR technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Brainsway Ltd ADR, which can be compared to its rivals. Please confirm Brainsway ADR coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Brainsway ADR is priced correctly, providing market reflects its regular price of 10.53 per share. Given that Brainsway has jensen alpha of 0.3143, we suggest you to validate Brainsway Ltd ADR's prevailing market performance to make sure the company can sustain itself at a future point.

Brainsway ADR Price Movement Analysis

The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Mid-point over period is an average of Brainsway ADR highest and lowest values attained during the given period. View also all equity analysis or get more info about midpoint over period overlap studies indicator.

Brainsway Predictive Daily Indicators

Brainsway intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Brainsway stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Brainsway Forecast Models

Brainsway time-series forecasting models is one of many Brainsway's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Brainsway's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Brainsway Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Brainsway stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BWAY shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Brainsway. By using and applying BWAY Stock analysis, traders can create a robust methodology for identifying BWAY entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin(0.1) (0.10) 
Gross Margin 0.77  0.85 
Profit Margin(0.24) (0.27) 
Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. Brainsway operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 100 people.

Current BWAY Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. BWAY analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. BWAY analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
14.5Buy5Odds
Brainsway Ltd ADR current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most BWAY analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand BWAY stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Brainsway ADR, talking to its executives and customers, or listening to BWAY conference calls.
BWAY Analyst Advice Details

BWAY Stock Analysis Indicators

Brainsway Ltd ADR stock analysis indicators help investors evaluate how Brainsway stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Brainsway shares will generate the highest return on investment. By understating and applying Brainsway stock analysis, traders can identify Brainsway position entry and exit signals to maximize returns.
Quick Ratio3.47
Fifty Two Week Low5.52
Revenue Growth12.30%
Shares Short Prior Month3.14k
Average Daily Volume Last 10 Day19.36k
Average Daily Volume In Three Month65.08k
Shares Percent Shares Out0.11%
Gross Margins81.88%
Forward Price Earnings-77.21
Float Shares11.24M
Fifty Two Week High11.77
Enterprise Value To Ebitda-50.56
Fifty Day Average9.84
Two Hundred Day Average8.58
Enterprise Value To Revenue5.73
Continue to Trending Equities. Note that the Brainsway ADR information on this page should be used as a complementary analysis to other Brainsway's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Brainsway Stock analysis

When running Brainsway ADR price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
The market value of Brainsway ADR is measured differently than its book value, which is the value of BWAY that is recorded on the company's balance sheet. Investors also form their own opinion of Brainsway's value that differs from its market value or its book value, called intrinsic value, which is Brainsway's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainsway's market value can be influenced by many factors that don't directly affect Brainsway ADR underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainsway's value and its price as these two are different measures arrived at by different means. Investors typically determine Brainsway value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainsway's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.